Matches in DBpedia 2014 for { <http://dbpedia.org/resource/SynBio> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- SynBio abstract "SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian and international pharmaceutical companies. The largest private participant of SynBio is the Human Stem Cells Institute (HSCI), a leading Russian biotech company, and the Russian Corporation of Nanotechnologies (RUSNANO) is a key investor. The project is a significant example of international cooperation between researchers in Russia, England, and Germany. Special project company SynBio LLC is headquartered in Moscow.Currently, SynBio LLC is developing nine drugs based on three biotechnology platforms (Histone, PolyXen and Gemacell) for the treatment of liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes mellitus.The SynBio project also entails the creation of modern production facilities. These facilities will be dedicated to the manufacturing of the company’s pharmaceutical substances and market-ready medicines once they have successfully undergone clinical testing.".
- SynBio industry Biotechnology.
- SynBio industry Pharmaceutical_drug.
- SynBio owner Human_Stem_Cells_Institute.
- SynBio owningCompany Human_Stem_Cells_Institute.
- SynBio thumbnail Synbio_logo.jpg?width=300.
- SynBio wikiPageExternalLink synbio-pharma.com.
- SynBio wikiPageExternalLink www.synbio-pharma.com.
- SynBio wikiPageID "33161940".
- SynBio wikiPageRevisionID "552074331".
- SynBio caption "Disambiguation with Synthetic Biology".
- SynBio hasPhotoCollection SynBio.
- SynBio homepage www.synbio-pharma.com.
- SynBio industry "Biotech Research and Pharmaceuticals".
- SynBio location "Moscow, Russia".
- SynBio logo File:Synbio_logo.jpg.
- SynBio name "SynBio".
- SynBio owner "RUSNANO, HSCI, FDS Pharma, Dmitry Genkin, Cryonix, and Pharmsynthez".
- SynBio subject Category:Biotechnology.
- SynBio subject Category:Companies_of_Russia.
- SynBio subject Category:Stem_cells.
- SynBio type Abstraction100002137.
- SynBio type CompaniesOfRussia.
- SynBio type Company108058098.
- SynBio type Group100031264.
- SynBio type Institution108053576.
- SynBio type Organization108008335.
- SynBio type SocialGroup107950920.
- SynBio type YagoLegalActor.
- SynBio type YagoLegalActorGeo.
- SynBio type YagoPermanentlyLocatedEntity.
- SynBio type Agent.
- SynBio type Company.
- SynBio type Organisation.
- SynBio type Organization.
- SynBio type Agent.
- SynBio type SocialPerson.
- SynBio type Thing.
- SynBio comment "SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian and international pharmaceutical companies. The largest private participant of SynBio is the Human Stem Cells Institute (HSCI), a leading Russian biotech company, and the Russian Corporation of Nanotechnologies (RUSNANO) is a key investor.".
- SynBio label "SynBio".
- SynBio label "سينبايو".
- SynBio sameAs m.0h7qy3k.
- SynBio sameAs Q7661923.
- SynBio sameAs Q7661923.
- SynBio sameAs SynBio.
- SynBio wasDerivedFrom SynBio?oldid=552074331.
- SynBio depiction Synbio_logo.jpg.
- SynBio homepage www.synbio-pharma.com.
- SynBio isPrimaryTopicOf SynBio.
- SynBio name "SynBio".